|
Marché Fermé -
Nasdaq
22:00:00 06/11/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 25,31 USD | -1,33% |
|
-8,13% | +22,86% |
| 27/10 | Neurogene Inc. présente de nouvelles données sur la thérapie génique NGN-401 contre le syndrome de Rett | CI |
| 08/10 | Neurogene Inc. : Opinion positive de JPMorgan Chase | ZM |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1,33% | -8,13% | -0,55% | -28,90% | +22,86% | -5,06% | - | - | - | 513 M | |
| -4,83% | +2,88% | -12,15% | -0,34% | +62,18% | +55,87% | +69,12% | +16,30% | - | 69,4 Md | |
| +0,02% | +1,42% | +0,42% | +8,98% | +13,81% | +12,77% | +75,21% | +195,69% | +6 359,22% | 57,24 Md | |
| -1,34% | +3,53% | +15,41% | +18,17% | +23,35% | +23,22% | +101,58% | -6,90% | +273,12% | 57,62 Md | |
| +2,62% | +1,68% | +4,56% | +16,95% | +20,59% | +28,91% | +37,01% | +8,08% | +264,43% | 43,65 Md | |
| +5,09% | +9,89% | +12,18% | +23,40% | +33,95% | +22,45% | +107,48% | +16,33% | +1 174,14% | 44,03 Md | |
| +8,24% | +0,51% | -3,80% | -2,80% | +141,41% | +213,26% | +792,66% | +487,47% | - | 38,08 Md | |
| -1,86% | +11,46% | +15,55% | +10,88% | +22,40% | +26,67% | +61,40% | +22,80% | +180,36% | 36,31 Md | |
| -2,97% | -6,89% | +48,38% | +86,42% | +74,00% | +91,79% | +74,60% | +17,33% | +204,58% | 32,61 Md | |
| -2,18% | +5,68% | -14,04% | +17,23% | +51,46% | +36,21% | -0,69% | -53,27% | - | 25,47 Md | |
| +5,19% | +1,62% | +8,72% | -13,69% | -34,27% | -38,39% | +379,89% | +248,48% | +872,01% | 23,86 Md | |
| +1,92% | -0,75% | -8,59% | -4,04% | -8,08% | -15,33% | -12,24% | -63,93% | - | 21,29 Md | |
| +2,86% | +0,17% | +8,33% | +11,64% | +16,28% | +10,29% | +142,46% | +190,84% | +1 958,98% | 17,76 Md | |
| +1,25% | +0,26% | +19,27% | +33,28% | +58,73% | +70,51% | +233,83% | +270,84% | +462,86% | 16,77 Md | |
| -0,45% | +1,79% | +17,34% | +27,21% | +42,05% | +50,08% | +72,12% | -11,24% | +122,16% | 17,35 Md | |
| +1,33% | +2,21% | +13,61% | +2,79% | - | - | - | - | - | 16,64 Md | |
| +7,17% | +2,42% | +6,72% | -4,87% | +199,74% | +184,32% | +358,47% | +1 547,39% | +865,04% | 14,86 Md | |
| +7,83% | -6,09% | +10,68% | +27,12% | +69,20% | +97,52% | +86,09% | -9,72% | +380,18% | 15 Md | |
| +1,53% | -3,13% | +26,63% | +27,03% | +12,36% | +27,96% | -20,60% | -23,62% | +167,11% | 15,11 Md | |
| +7,98% | +5,30% | +5,65% | +64,90% | +28,79% | +5,49% | - | - | - | 12,85 Md | |
| Moyenne | +1,91% | -1,16% | +8,72% | +16,07% | +44,78% | +47,29% | +150,49% | +167,82% | +1 021,86% | 28,82 Md | |
| Moyenne pondérée par Capi. | +1,09% | +0,81% | +7,29% | +16,11% | +43,51% | +48,03% | +144,48% | +121,52% | +1 384,01% |
- Bourse
- Actions
- Action NGNE
- Secteur Neurogene Inc.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
